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Abstract: Background Atrial fibrillation (AF) occurs in dogs with myxomatous mitral valve disease
(MMVD) as a consequence of left atrial (LA) dilatation, and it affects survival and quality of life.
Objectives To evaluate the usefulness of echocardiography in predicting the first occurrence of AF in
dogs with MMVD. Animals Forty‐four client‐owned dogs with MMVD, 22 dogs that developed AF, and
22 dogs that maintained sinus rhythm. Methods Retrospective observational study. Medical databases
were reviewed for dogs that developed AF during the year after diagnosis of MMVD (AF group). The
last echocardiographic examination obtained while still in sinus rhythm was used to derive selected
variables. For each dog with AF, a control dog matched for body weight, class of heart failure, and
LA dimension was selected. Echocardiographic results including LA volumes and LA speckle tracking
echocardiography (STE)‐derived variables were measured. Results Among the tested echocardiographic
variables, only LA diameter (P = .03) and left ventricular internal diameter in diastole (P = .03) differed
significantly between groups, whereas body weight‐indexed variables of cardiac dimension as well as LA
volumes and volume‐derived functional variables were not different. Among the STE‐derived variables,
peak atrial longitudinal strain (PALS) results differed significantly between the AF group (23.8% ± 8.6%)
and the control group (30.5% ± 9.6%; P = .03). A value of PALS ฀28% predicted AF occurrence with
sensitivity and specificity of 0.80 and 0.65, respectively. Conclusions and Clinical Importance Absolute
cardiac diameters and LA STE (in particular, PALS) are useful echocardiographic predictors for the
development of AF in dogs with MMVD.
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Abstract
Background: Atrial fibrillation (AF) occurs in dogs with myxomatous mitral valve dis-
ease (MMVD) as a consequence of left atrial (LA) dilatation, and it affects survival
and quality of life.
Objectives: To evaluate the usefulness of echocardiography in predicting the first
occurrence of AF in dogs with MMVD.
Animals: Forty-four client-owned dogs with MMVD, 22 dogs that developed AF, and
22 dogs that maintained sinus rhythm.
Methods: Retrospective observational study. Medical databases were reviewed for
dogs that developed AF during the year after diagnosis of MMVD (AF group). The
last echocardiographic examination obtained while still in sinus rhythm was used to
derive selected variables. For each dog with AF, a control dog matched for body
weight, class of heart failure, and LA dimension was selected. Echocardiographic
results including LA volumes and LA speckle tracking echocardiography (STE)-derived
variables were measured.
Results: Among the tested echocardiographic variables, only LA diameter (P = .03)
and left ventricular internal diameter in diastole (P = .03) differed significantly
between groups, whereas body weight-indexed variables of cardiac dimension as well
as LA volumes and volume-derived functional variables were not different. Among
the STE-derived variables, peak atrial longitudinal strain (PALS) results differed signif-
icantly between the AF group (23.8% ± 8.6%) and the control group (30.5% ± 9.6%;
P = .03). A value of PALS ≤28% predicted AF occurrence with sensitivity and specific-
ity of 0.80 and 0.65, respectively.
Conclusions and Clinical Importance: Absolute cardiac diameters and LA STE (in par-
ticular, PALS) are useful echocardiographic predictors for the development of AF in
dogs with MMVD.
Abbreviations: AF, atrial fibrillation; BW, body weight; CHF, congestive heart failure; HR, heart rate; LA, left atrial; LAP, left atrial volume at the onset of the P wave; LAV max, maximal left atrial
volume; LAV min, minimal left atrial volume; LV, left ventricular; MMVD, myxomatous mitral valve disease; NSR, normal sinus rhythm; PACS, peak atrial contraction strain; PALS, peak atrial
longitudinal strain; ROC, receiver operating characteristic; STE, speckle tracking echocardiography.
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1 | INTRODUCTION
Atrial fibrillation (AF) is a common arrhythmia in dogs with underlying
cardiac disease associated chamber dilatation.1 Dogs without underly-
ing cardiac disease have a better prognosis than those with cardiac
disease, regardless of whether or not it is associated with congestive
heart failure (CHF).1 Because dogs with left atrial (LA) dilatation and
higher body weight (BW) are at increased risk of developing AF, this
arrhythmia is detected most frequently in large breed dogs with
dilated cardiomyopathy.1-3 However, when present in medium-to-
large-breed dogs with myxomatous mitral valve disease (MMVD), AF
represents an independent risk factor for cardiac death.4 Ventricular
response rate is another pivotal factor affecting clinical presentation
and outcome in dogs with AF. Animals with increased heart rate (HR),
as measured instantaneously or by calculating the mean HR over
24 hours using a Holter monitor, or poor pharmacological rate control
have worse outcome.1,4,5 Therefore, appropriate control of mean HR
using nodal blockers, such as digoxin and diltiazem, should be carried
out to increase life expectancy of these patients.5 Thus, early detec-
tion of AF in dogs with cardiac disease is extremely important in order
to begin effective treatment and improve survival.
In people, several studies have evaluated the usefulness of sur-
face ECG and transthoracic echocardiography in predicting the future
occurrence of AF.6-9 Among these, advanced echocardiographic tech-
niques such as LA tissue Doppler imaging and LA speckle tracking
echocardiography (STE) have been shown to be valuable tools for
predicting AF occurrence in humans with cardiac disease or normally-
structured hearts.10-13 Left atrial tissue Doppler imaging and STE also
have been applied in both clinically healthy dogs and dogs with
MMVD.14-19 In particular, LA STE-derived strain has been shown to
decrease progressively as the disease advances,15 and it is a predictor
of cardiac death in dogs with MMVD.17
Our aim was to evaluate the clinical usefulness of several indices
of LA and left ventricular (LV) morphology and function to predict the
future occurrence of AF in a population of dogs with naturally occur-
ring MMVD.
2 | MATERIALS AND METHODS
2.1 | Animals
The medical databases of the veterinary teaching hospitals of the Uni-
versities of Bologna and Padova were retrospectively reviewed from
January 2011 to December 2018 searching for all dogs with MMVD
that developed AF during the 12 months after diagnosis of MMVD
and inclusion in the study (AF group). Only dogs with at least 1 echo-
cardiographic examination performed before the occurrence of AF
that showed normal sinus rhythm (NSR) were considered. The diagno-
sis of AF was made by analyzing a 6- or 12-lead surface ECG by a
board-certified cardiologist. Information regarding clinical variables
including breed, sex, BW, and age; presence or absence of CHF; class
of heart failure20; drugs received; and the time between the last echo-
cardiographic examination performed in NRS and the diagnosis of AF
were recorded. Echocardiographic examinations were retrieved from
a dedicated server as digital imaging and communications in medicine
(DICOM) files and analyzed by a single operator using dedicated soft-
ware for image analysis (OsiriX MD Software, Pixeo SARL, Geneva,
Switzerland; QLAB quantification software version 9.1, Philips
Healthcare, Monza, Italy). A control group was created by selecting
dogs with MMVD during the same period of time. These animals mat-
ched those of the AF group based on similar signalment, same heart
failure class, and similar LA dimension as expressed as the ratio
between the diameter of the left atrium and aorta described below.
Dogs in the control group had a follow-up time that was longer than
the time between the last echocardiographic examination in NSR and
the occurrence of AF for the corresponding patient in the AF group.
2.2 | Echocardiography
Transthoracic echocardiographic examinations were reviewed and
analyzed by a board-certified cardiologist to confirm the diagnosis of
MMVD and obtain LA and LV morphological and functional variables
as well as Doppler-derived variables. All examinations were performed
using echocardiographic units (iE33 and CX50 ultrasound systems,
Philips Healthcare) from the same manufacturer with similar software
and technology, and equipped with a dedicated multifrequency
phased array transducer (S5-1 pure-wave phased array transducer,
Philips Healthcare). Echocardiographic diagnosis of MMVD was made
by observing typical thickening, prolapse of the mitral valve, or insuffi-
ciency of the mitral valve on color Doppler examination, or a combina-
tion of these. Wall thickness and chamber diameter of the LV were
obtained from 2-dimensional guided M-mode images acquired from a
right parasternal short axis view at the level of the papillary muscles.
In particular, LV end-diastolic and end-systolic dimensions were nor-
malized to BW and compared to previously published reference inter-
vals.21 Fractional shortening then was calculated using the
appropriate formula. The LA diameter and aortic diameter were mea-
sured on 2-dimensional images obtained from a right parasternal short
axis view at the basilar level, as previously described.22 The LV dia-
stolic inflow was recorded from the left apical 4 chamber view by
placing the sample volume at the level of the mitral valve on the ven-
tricular side. The peak velocity of the early diastolic flow wave, peak
velocity and duration of the late diastolic flow wave, and ratio
between the 2 peak velocities were measured.
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The LA volumes were measured only from a left apical 4-chamber
view using the area-length method, as previously described.23 The fol-
lowing variables were calculated: maximal LA volume (LAV max); mini-
mal LA volume (LAV min); LA volume at the onset of the P wave
(LAP); LA total emptying volume (LAV max − LAV min); LA expansion
index ([LAV max − LAV min]/LAV min); LA passive emptying volume
(LAV max − LAP); LA passive emptying percentage of total emptying
([LAV max − LAP]/[LAV max − LAV min]); LA active emptying volume
(LAP − LAV min); LA active emptying percentage of total emptying
([LAP − LAV min]/[LAV max − LAV min]). Finally, LAV max, LAV min,
TABLE 1 Signalment and
echocardiographic variables in a
population of 44 dogs with myxomatous
mitral valve disease that developed or
not atrial fibrillation during the
following year
Variable Control group (n = 22) AF group (n = 22) P value
BW (kg) 13.0 (8.4-18.0) 11.4 (9.2-20.4) .80
Age (years) 11.5 ± 2.1 11.5 ± 2.0 .99
Last echo - event (days) 291.0 (178.3-566.3) 142.5 (64.0-324.3) .01
Heart rate (bpm) 137.6 ± 28.4 149.6 ± 32.9 .20
LA/Ao 2.2 ± 0.5 2.5 ± 0.5 .09
LA diam (mm) 38.1 (35.8-43.7) 42.3 (38.9-50.2) .03
Ao (mm) 18.6 ± 4.2 18.6 ± 4.2 .99
E wave (m/s) 1.2 (1.0-1.5) 1.5 (1.1-1.6) .12
A wave (m/s) 0.7 ± 0.2 0.7 ± 0.2 .95
E/A 2.0 (1.4-2.4) 2.0 (1.7-3.0) .34
A wave dur (ms) 82.3 ± 12.8 80.4 ± 17.0 .69
LVIDD (mm) 42.0 (40.2-48.1) 47.2 (43.95-52.05) .03
LVIDS (mm) 24.6 (21.93-28.5) 26.5 (22.08-29.08) .50
LVIDDn 2.1 ± 0.4 2.3 ± 0.4 .13
LVIDSn 1.1 (1.0-1.2) 1.1 (1.0-1.3) .41
LV FS (%) 43.3 ± 6.9 44.1 ± 8.1 .72
LAVmax (mL) 62.8 ± 37.4 74.0 ± 49.1 .40
LAVmin (mL) 32.4 ± 25.7 39.5 ± 31.9 .42
LAVp (mL) 42.8 ± 26.2 54.7 ± 46.6 .30
LAVmax:BW (mL/kg) 4.8 ± 2.7 5.5 ± 3.2 .49
LAVmin:BW (mL/kg) 2.5 ± 1.8 2.9 ± 2.2 .52
LAVp:BW (mL/kg) 3.3 ± 1.9 3.9 ± 2.7 .37
LAEV (mL) 30.5 ± 14.7 34.5 ± 25.2 .52
LAEi (%) 120.1 ± 57.6 121.1 ± 85.6 .96
LAPEV (mL) 20.0 ± 12.8 19.3 ± 13.0 .85
LAPE (%) 63.4 ± 15.5 59.4 ± 20.6 .46
LAAEV (mL) 10.5 ± 5.8 15.2 ± 20.8 .31
LAAE (%) 36.6 ± 14.5 40.7 ± 20.6 .46
Strain PALS (%) 30.5 ± 9.6 23.8 ± 8.6 .03
Strain PACS (%) 7.0 (2.0-12.8) 4.5 (2.3-8.5) .31
CSI (%) 24.4 ± 16.8 22.9 ± 13.2 .76
Note: Normally and not normally distributed data are presented as mean ± SD and median (interquartile
range), respectively.
Abbreviations: A wave, mitral valve A wave peak velocity; A wave dur, A wave duration; AF, atrial fibrilla-
tion; Ao, aorta diameter; BW, body weight; CSI, contraction strain index; E wave, mitral valve E wave
peak velocity; E/A, mitral valve peak E and A wave velocity ratio; LA diam, left atrial diameter; LA/Ao, left
atrial diameter to aorta ratio; LAAE, left atrial active emptying percentage of total emptying; LAAEV, left
atrial active emptying volume; LAEi, left atrial expansion index; LAEV, left atrial emptying volume; LAPE,
left atrial passive emptying percentage of total emptying; LAPEV, left atrial passive emptying volume; Last
echo-event, time passed from the last echocardiographic exam to development of atrial fibrillation/last
contact; LAVmax, left atrial maximal volume; LAVmin, left atrial minimal volume; LAVp, left atrial volume
on P wave; LV FS, left ventricular fractional shortening; LVIDD, left ventricular internal diameter in dias-
tole; LVIDDn, left ventricular internal diameter in diastole indexed to body weight; LVIDS, left ventricular
internal diameter in systole; LVIDSn, left ventricular internal diameter in systole indexed to body weight;
strain PACS, peak atrial contraction strain; strain PALS, peak atrial longitudinal strain.
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and LAP indexed to BW were calculated by dividing these variables
by the BW of the dog expressed in kilograms.
The LA STE was performed as described in a previous study.15
Briefly, from a left apical 4-chamber view, 3 points were selected on
the left atrium (2 at the mitral valve annulus and 1 on the atrial roof)
and the software automatically drew a region of interest with 7 differ-
ent subregions. The perfect track of the segments of the LA walls was
manually evaluated and edited as needed. The time/strain curves then
were generated, and the following values were annotated: peak atrial
longitudinal strain (PALS; representing the peak strain value during LV
contraction); peak atrial contraction strain (PACS; representing the
strain value just before LA active contraction on the peak of the P
wave of the ECG trace); and contraction strain index, calculated using
the formula: ([PACS/PALS] × 100).
All measurements were replicated on 3 consecutive beats, and
the mean values then were calculated. The HR provided by the con-
tinuous ECG recording performed during each echocardiographic
examination was annotated.
2.3 | Variability study
Interobserver and intraobserver variability of LA STE already has been
studied in dogs with MMVD, and it appeared to be clinically accept-
able.15 Because 2 different echocardiographic units were used at 2
enrollment centers, the effect of the echocardiographic machine was
evaluated by selecting 5 dogs not included in the study population. In
particular, 5 dogs with or without MMVD were recruited from the
university students and hospital staff, and a complete echocardio-
graphic examination was repeated using both machines during the
same day in the same dogs, approximately 1 hour apart. At the end of
the variability study, the operator performed the STE analysis on the
10 studies that were anonymized to keep the operator blind to the
dogs' identities. Variability then was calculated using the coefficient
of variation, as previously described.24
2.4 | Statistical analysis
All statistical analyses were performed using 2 commercial dedicated
software programs (Prism 7, GraphPad Software Inc, San Diego, Cali-
fornia; SAS version 9.3, SAS Institute Inc, Cary, North Carolina). Distri-
bution of continuous data was assessed visually and by using a
D'Agostino-Pearson normality test. Normally distributed data are
expressed as mean ± SD, whereas nonnormally distributed variables
are presented as median (interquartile range [IQR]). Continuous vari-
ables were compared between groups using an unpaired t test or a
Mann-Whitney test as needed, whereas categorical data were com-
pared using a Chi-squared test. A univariate analysis was performed
to determine whether a significant relationship existed between echo-
cardiographic variables and future occurrence of AF. Predictors with
P < .1 were retained for the subsequent multivariable analysis. In this
second step, the variables were considered to significantly affect
outcome when P < .05. The relative risk and the 95% confidence
interval (CI) were calculated. Receiver operating characteristic (ROC)
curves were obtained by plotting sensitivity versus specificity to
determine the ability of each echocardiographic variable to predict
future AF occurrence. The area under the curve of the ROC curves
for each variable was compared. Moreover, for each variable, the opti-
mal cutoff corresponding to the value closest to the upper left corner
of the graph was identified (Youden criterion). Sensitivity and specific-
ity were calculated by use of the cutoffs determined from the ROC
curves. A value of P < .05 was considered significant for all analyses.
3 | RESULTS
3.1 | Demographic variables
Forty-four dogs were included in the study (22 dogs for each group).
No difference was found between groups for BW (P = .8), age
(P = .99), and sex (P = .5; Table 1). In the AF group, the most common
breed was the mixed breed (14/22 dogs, 63.6%), followed by 1 each
of the following breeds: Dachshund, Cavalier King Charles spaniel,
Springer Spaniel, Cocker Spaniel, Jack Russell Terrier, Drahthaar, Ital-
ian Griffon, and Border Collie. In the control group, the most common
breed was the mixed breed (16/22 dogs, 72.7%), followed by Dachs-
hund and Beagle (2/22 dogs each, 9.1%), and 1 each of the Shar-Pei
and Bolognese (4.5%). No difference in breed distribution was found
between groups (P = .75). The classes of heart failure were perfectly
F IGURE 1 Receiver operating characteristic curve for peak atrial
longitudinal strain for the prediction of first occurrence of atrial
fibrillation in a population of 44 dogs with myxomatous mitral valve
disease. The area under the curve represented by the thicker line is
0.721 (95% confidence interval, 0.555-0.888). The overall most
accurate cutoff point identified on the curve was peak atrial
longitudinal strain ≤28%, which had a sensitivity and a specificity of
0.80 and 0.65, respectively
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matched between the 2 groups, with 17 dogs (77.3%) in each group
being in the symptomatic class (stage C), 3 dogs (13.6%) in a compen-
sated state with cardiomegaly (stage B2), and 2 dogs (9.1%) in a com-
pensated state without cardiomegaly (stage B1). Drugs used for the
treatment of the underlying valvular disease were furosemide,
pimobendan, benazepril, spironolactone, enalapril, hydrochlorothia-
zide, torasemide, amlodipine, sotalol, and mexiletine. No difference in
terms of drugs administered between the 2 groups was found (P = .9).
Median time from the last echocardiographic examination and the
occurrence of AF in the study group (142.5 days; IQR, 64-324.3 days)
was significantly shorter compared to the follow-up time of dogs in
the control group (median, 291 days; IQR, 178.3-566.3 days; P = .01).
3.2 | Echocardiography
Among the conventional echocardiographic variables, LA diameter
was higher in dogs of the AF group (median, 42.3 mm; IQR, 38.9-
50.2 mm) compared to that of dogs of the control group (median,
38.5 mm; IQR, 35.8-43.7 mm; P = .03). Similarly, LV internal diameter
at end diastole was larger in dogs of the AF group (median, 47.2 mm;
IQR, 44.0-52.1 mm) compared to that of dogs of the control group
(median, 42.0 mm; IQR, 40.2-48.1 mm; P = .03). None of the Doppler-
derived variables, LA volumes, and LA volume-derived functional vari-
ables differed between the 2 groups. Among the STE-derived vari-
ables, mean PALS was lower in the AF group (23.8% ± 8.6%)
compared to that of dogs of the control group (30.5% ± 9.6%; P = .03;
Table 1).
Univariate analysis of the effect of echocardiographic variables
identified LA/Ao (P = .06), LA diam (P = .09), and PALS (P = .03) as
potential predictors of AF. Because of multicollinearity among these
predictors, the multivariable analysis did not converge. The only vari-
able having a significant effect on the future development of AF was
PALS, with a Wald chi-square of 4.76 and relative risk of 0.96 (95%
CI, 0.93-0.99). Because PALS was the only variable showing signifi-
cant impact on the development of AF, ROC curve was created for
this variable only. The area under the ROC curve was 0.721 (SE,
0.085; 95% CI, 0.555-0.888), and the optimal cutoff to predict future
onset of AF was ≤28%, with sensitivity and specificity of 0.80 and
0.65, respectively (Figure 1; Table 2).
3.3 | Variability study
The variability between the 2 echocardiographic machines was clini-
cally acceptable (<15%) for all STE-derived variables. In particular, the
corresponding coefficients of variation were 12.9, 14.8, and 11.0% for
PALS, PACS, and the contraction strain index, respectively.
4 | DISCUSSION
We showed that, in dogs with MMVD, absolute LA and LV dimen-
sions are higher in those subjects that develop AF during the year
after the echocardiographic examination. However, only STE-derived
PALS represents an independent predictor of AF development in
these dogs after univariate analysis, with an increased risk of arrhyth-
mia when PALS ≤28%.
The occurrence of AF in dogs with CHF usually is the result of LA
remodeling with chamber dilatation and interstitial fibrosis.25 Because
a critical atrial mass is needed to perpetuate the arrhythmia,26 dilata-
tion of the left atrium usually is present in small animals. This factor is
even more important in small breed dogs, such as those that typically
are affected by MMVD, in which LA dilatation usually accompanies
the most advanced stages of the disease. Body weight is a risk factor
for the development of AF in dogs,2 and giant breeds usually are more
frequently affected by the arrhythmia.1 In our study, all dogs with
MMVD were included, which is a different approach from that of a
previous study that evaluated the prognostic relevance of AF in
medium-to-large-breed dogs (>15 kg) with MMVD.4 Therefore, the
animals included in our study had severely dilated LA likely associated
with relevant atrial remodeling and fibrosis that allowed for mainte-
nance of the arrhythmia. Therefore, studying LA dimension using
echocardiography can give relevant information about the stratifica-
tion of patients with cardiac disease, because several studies in people
have indicated that LA enlargement represents a risk factor for devel-
opment of cardiac events, including first onset of AF.8,27-29
The dilatation of the LA is not a simple elongation of the myocar-
dial fibers, but an active process of myocardial remodeling. This remo-
deling implies myofiber hypertrophy, changes in the interstitial matrix,
and fibrosis.30-32 In a canine model of CHF induced by tachy-pacing,
the heart failure itself promoted atrial interstitial fibrosis, with subse-
quent abnormal local conduction and occurrence of sustained AF.25
This process, together with abnormal LA afterload and diastolic dys-
function of the left ventricle, leads not only to enlargement of the
chamber, but also to abnormal systolic properties.33,34 In people,
abnormal LA function represents a stronger predictor of AF occur-
rence when compared to echocardiographic evaluation of LA dimen-
sions alone.35 Thus, several echocardiographic variables reflecting LA
systolic function have been used to predict the occurrence of AF. In
particular, volume-derived functional variables, such as total, active,
and passive ejection fractions can be useful for detecting LA
TABLE 2 Diagnostic accuracy of
peak atrial longitudinal strain in
predicting first occurrence of atrial
fibrillation in dogs with myxomatous
mitral valve disease
AUC ± SE 95% confidence interval Cutoff Sensitivity Specificity
0.721 ± 0.085 0.555-0.888 ≤47% 0.95 0.05
≤28% 0.80 0.65
≤12% 0.10 1.00
Abbreviation: AUC, area under the curve.
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dysfunction.34,35 Moreover, Doppler-derived transmitral wave flow
velocities and velocity time integrals can be used not only to assess
LV diastolic function, but also to estimate LA booster function.35 In
our study of dogs with MMVD, none of these variables differed
between animals that developed AF and those that maintained NSR.
Moreover, in other studies performed in dogs with MMVD, none of
the LA volume- and area-derived functional variables predicted car-
diac-related death and occurrence of CHF.17,36 Therefore, these echo-
cardiographic variables seem to have limited value in detecting
clinically relevant LA dysfunction in dogs with MMVD.
Left atrial strain can be analyzed using the tissue Doppler tech-
nique or STE software. Both methods have been used in dogs, and
the latter shows better reproducibility and clinical relevance.14,15 In a
recent study performed on dogs with different types of cardiac dis-
ease, tissue Doppler appeared to be useful in predicting the future
onset of AF.37 In particular, the time between the onset of the P wave
on the ECG and the peak of the last diastolic wave recorded on the
mitral annulus differed between dogs that developed AF in the follow-
ing months and those that did not.37 This variable is an indicator of
atrial electromechanical delay, but does not directly reflect the systolic
properties of the chamber.34 Left atrial tissue Doppler imaging, how-
ever, is an angle-dependent technique that suffers from several limita-
tions and has limited clinical use in veterinary medicine.14 In contrast,
the STE-derived deformation technique is more reproducible and clin-
ically useful. In dogs with MMVD, PALS progressively decreases while
heart failure class advances and LA dilatation becomes worse.16,18
Moreover, lower PALS values indicate increased risk of cardiac death
in dogs with MMVD.17 Therefore, PALS is a valuable echocardio-
graphic variable to noninvasively assess LA mechanical dysfunction in
dogs with cardiac disease.
In people with AF, peak reservoir strain and strain rate inversely
predict the extent of LA fibrosis, as assessed by cardiac magnetic res-
onance imaging.12 Therefore, because interstitial fibrosis plays an
important role in the occurrence and maintenance of AF, STE vari-
ables can be helpful in better characterizing the disease process and
pathologic condition of the LA. Moreover, several studies in people
now have shown that STE variables can identify subtle dysfunction of
the LA and predict future occurrence (or reoccurrence) of AF indepen-
dently of other echocardiographic variables.10-13,38 In our study, a
decrease in PALS was the only variable that could predict future
occurrence of AF in the univariate model. Because all of the other
echocardiographic variables reflecting LA volume did not differ
between groups, PALS might indicate the presence of more severe
myocardial fibrosis in those dogs that developed arrhythmia in the
subsequent months. Although no therapeutic strategies have been
clinically useful to prevent occurrence of AF in dogs, recognition of
increased risk for arrhythmia development can suggest the need for
more frequent evaluation and treatment optimization for concomitant
cardiac diseases.
Our study has some limitations. First, the number of dogs enrolled
was low, which was a consequence of the difficulty of locating
patients with MMVD that developed AF during the follow-up time
and the low prevalence of arrhythmia in this specific population of
animals. Second, although LA STE has been determined to be feasible
and reproducible in dogs,15,18 the technique requires high-quality
images, dedicated software, and expertise for the analysis. Moreover,
LV STE has been shown to produce different results according to the
manufacturer of the machine used for the analysis.39 Thus far, it is
unknown if this phenomenon also is true for LA STE, but it is possible
that studies performed using different software will deliver different
results.
In conclusion, we showed that, together with absolute LA and LV
diameters, the use of LA STE could predict the future development of
AF in dogs with MMVD. In particular, PALS was the best predictor of
AF in these animals.
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